{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:19:28Z","timestamp":1790205568075,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972942"],"award-info":[{"award-number":["81972942"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ajpath.2023.01.016","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T16:06:52Z","timestamp":1681834012000},"page":"567-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis"],"prefix":"10.1016","volume":"193","author":[{"given":"Wenjie","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2023.01.016_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2023.01.016_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2023.01.016_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","article-title":"Highly effective new treatments for psoriasis target the IL-23\/type 17 T cell autoimmune axis","volume":"68","author":"Kim","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajpath.2023.01.016_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2023.01.016_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2023.01.016_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2340\/00015555-1737","article-title":"Phosphoinositide-3 kinase\/protein kinase-B\/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target?","volume":"94","author":"Huang","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.it.2017.12.002","article-title":"Protein kinase CK2: an emerging regulator of immunity","volume":"39","author":"Gibson","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/ph10010027","article-title":"Protein kinase CK2: intricate relationships within regulatory cellular networks","volume":"10","author":"Nu\u00f1ez de Villavicencio-Diaz","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ajpath.2023.01.016_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41392-021-00567-7","article-title":"Protein kinase CK2: a potential therapeutic target for diverse human diseases","volume":"6","author":"Borgo","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajpath.2023.01.016_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/mi.2012.57","article-title":"Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation","volume":"6","author":"Koch","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib12","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1038\/emm.2017.132","article-title":"Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation","volume":"49","author":"Jang","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ajpath.2023.01.016_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imm.12446","article-title":"Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation","volume":"145","author":"Huang","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.ajpath.2023.01.016_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00373381","article-title":"Casein kinase II activity in psoriatic epidermis","volume":"284","author":"Mitev","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ajpath.2023.01.016_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1013152621029","article-title":"Transcriptional coordination of the genes encoding catalytic (CK2alpha) and regulatory (CK2beta) subunits of human protein kinase CK2","volume":"227","author":"Pyerin","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ajpath.2023.01.016_bib16","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy","volume":"70","author":"Siddiqui-Jain","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2023.01.016_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.14112","article-title":"Mouse models of psoriasis and their relevance","volume":"45","author":"Nakajima","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tig.2010.06.006","article-title":"Psoriasis genetics: breaking the barrier","volume":"26","author":"Roberson","year":"2010","journal-title":"Trends Genet"},{"key":"10.1016\/j.ajpath.2023.01.016_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing [gamma delta] T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2023.01.016_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib21","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jid.2020.11.024","article-title":"CYP1A1 enzymatic activity influences skin inflammation via regulation of the AHR pathway","volume":"141","author":"Kyoreva","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12951-021-00842-3","article-title":"Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation","volume":"19","author":"Gangadevi","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.ajpath.2023.01.016_bib23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2023.01.016_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/biof.96","article-title":"Emergence of protein kinase CK2 as a key target in cancer therapy","volume":"36","author":"Trembley","year":"2010","journal-title":"Biofactors"},{"key":"10.1016\/j.ajpath.2023.01.016_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/1097-0347(200007)22:4<341::AID-HED5>3.0.CO;2-3","article-title":"Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in\u00a0vitro","volume":"22","author":"Faust","year":"2000","journal-title":"Head Neck"},{"key":"10.1016\/j.ajpath.2023.01.016_bib27","first-page":"4008","article-title":"Alterations of microRNAs are associated with impaired growth of MCF-7 breast cancer cells induced by inhibition of casein kinase 2","volume":"7","author":"Li","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib28","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1038\/oncsis.2016.82","article-title":"CK2 abrogates the inhibitory effects of PRH\/HHEX on prostate cancer cell migration and invasion and acts through PRH to control cell proliferation","volume":"6","author":"Siddiqui","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ajpath.2023.01.016_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13770-018-0145-7","article-title":"Keratinocyte migration in a three-dimensional in\u00a0vitro wound healing model co-cultured with fibroblasts","volume":"15","author":"Iyer","year":"2018","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.ajpath.2023.01.016_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/bjd.13513","article-title":"Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation","volume":"172","author":"Pal","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/sj.jid.5700280","article-title":"Signaling downstream of p38 in psoriasis","volume":"126","author":"Arthur","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2023.01.016_bib32","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1073\/pnas.1508990112","article-title":"Inflammation induces dermal V[gamma]4+ [gamma delta]T17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses","volume":"112","author":"Ram\u00edrez-Valle","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2023.01.016_bib33","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1038\/cddis.2012.69","article-title":"Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis","volume":"3","author":"Madonna","year":"2012","journal-title":"Cell Death Dis"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944023000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944023000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:08:40Z","timestamp":1762081720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944023000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0002944023000494"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2023.01.016","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2023.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}